The first FcRn blocker for both adult and pediatric generalized myasthenia gravis has been approved by the FDA, based on data showing sustained symptom improvement and IgG reduction in clinical trials.
Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.
Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A large Parkinson’s study found that a decline in dopamine transporter signals in the less affected putamen tracks worsening motor symptoms, supporting the use of DaT imaging for monitoring disease progression.
Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.